AMAG : Analysis & Opinions

  1. AMAG Pharmaceuticals 3Q Net 43 Cents/Share (AMAG)

    November 4, 2016
    AMAG's 3Q earnings and revenue beat analyst estimates due to robust sales of its Makena drug for pregnant women.
  2. Are These 3 Biotech Stocks Dirt Cheap? (ABBV, AMAG)

    June 22, 2015
    Everyone loves a bargain, and investors like me are no exception. That's why I like to check in with stocks every quarter ...
Trading Center